Treatment of Life Threatening Haemorrhage in Infant with Haemangiomatosis and with Manifestations of the Kassabach-Merrit Syndrome by Activated Recombinant Factor VII (rFVIIa)

Czech version

Authors: J. Blatný; O. Magnová; J. Štěrba
Authors‘ workplace: Oddělení dětské onkologie, FN Brno - Dětská nemocnice, primář MUDr. J. Štěrba, PhD.
Published in: Čes-slov Pediat 2002; (4): 172-173.
Category:

Overview

Recombinant Factor VIIa (rFVIIa) was successfully used to avert life-threatening bleeding in an infant with retroperitoneal haemangiomatosis and Kassabach-Merrit Syndrome. The use of rFVIIa in this patient was life-saving and enabled multimodal treatment of haemangiomatosis with chemotherapy and radiotherapy. This clinical experience thus contributes to the idea of further studies of rFVIIa as a haemostatic agent.

Key words:
Reombinant Factor VIIa, rFVIIa, haemangiomatosis, Kassabach-Merrit Syndrome

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.